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Abstract
Mitochondrial DNA (mtDNA) variation can affect phenotypic variation; therefore, knowing its distribution within and among
individuals is of importance to understanding many human diseases. Intra-individual mtDNA variation (heteroplasmy) has
been generally assumed to be random. We used massively parallel sequencing to assess heteroplasmy across ten tissues
and demonstrate that in unrelated individuals there are tissue-specific, recurrent mutations. Certain tissues, notably kidney,
liver and skeletal muscle, displayed the identical recurrent mutations that were undetectable in other tissues in the same
individuals. Using RFLP analyses we validated one of the tissue-specific mutations in the two sequenced individuals and
replicated the patterns in two additional individuals. These recurrent mutations all occur within or in very close proximity to
sites that regulate mtDNA replication, strongly implying that these variations alter the replication dynamics of the mutated
mtDNA genome. These recurrent variants are all independent of each other and do not occur in the mtDNA coding regions.
The most parsimonious explanation of the data is that these frequently repeated mutations experience tissue-specific
positive selection, probably through replication advantage.
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Introduction
Mitochondrial DNA (mtDNA) heteroplasmy is commonly
thought to be the product of either maternal inheritance [1] or
rare, random somatic mutations that undergo subsequent expan-
sion within an individual via genetic drift [2,3]. Inherited
heteroplasmy should be present in many, but perhaps not all,
tissues while somatic mutations spread only as a result of cell
division subsequent to the mutation event. Somatic mutations will
be restricted to those cells or tissues derived from a common
progenitor, and should follow patterns of development. Such intra-
individual patterns should therefore differ among individuals as a
function of where and when the initial mutation occurred.
Under these standard models, both inherited and somatic
heteroplasmies should differ among unrelated individuals. How-
ever, until recent advances in sequencing technology it was
impossible to assay low levels of heteroplasmy across the entire
mitochondrial genome. We applied massively parallel sequencing
technology to test these models by deeply sequencing the same ten
tissues from two unrelated individuals. Unexpectedly we found
that certain tissues, notably kidney, liver and skeletal muscle, have
recurrent mtDNA mutations that were undetectable in other
tissues in the same individuals. These mutations were found across
unrelated individuals in these same tissues. Neither the maternal
inheritance nor the random somatic mutation models explain the
observed patterns of recurrent mtDNA heteroplasmy. The
common recurrence of these tissue-specific mutations indicates a
completely different model of mtDNA heteroplasmy, namely a
decidedly non-random process that results in particular mutations,
but only in specific tissues.
Results
Sequencing, Coverage and Copy Number
Next generation sequencing provides several advantages over
previous methods in that it allows detection of very low
heteroplasmy levels across the entire mtDNA genome without
having to target specific sites. We sequenced mtDNA from 10
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tissues (kidney, lung, liver, small bowel, large bowel, skeletal
muscle, spleen, brain white matter, skin above belt and skin below
belt) obtained at autopsy from two cancer-free individuals (Text
S1). In brief, mtDNA sequences were generated as 100 nt paired-
end reads on Illumina HiSeq 2000 machines, were aligned to the
human reference genome rCRS [4] using BWA [5], and then were
locally realigned and recalibrated using GATK [6]. Variants were
reported as heteroplasmic if their frequencies were $1% on both
strands from reads with a mapping quality score $30. We further
eliminated variants with any of the following artifacts: strand bias,
low average base quality score, or clustering at read ends. Strand
bias was evaluated at both base pair and motif levels. We identified
20 heteroplasmic sites with mutation levels .1% in our two
subjects (Table 1).
The coverage of mtDNA sequencing varied across tissues,
ranging from over 7,000 to almost 80,000 (Figure 1A). By
comparing mtDNA coverage to that for autosomal chromosomes,
we estimated the mtDNA copy number per cell for each sample
(Figure 1B). The two subjects had similar estimated mtDNA copy
numbers in each tissue with values consistent with expectations
based on previous data, ranging from a few hundred mtDNA per
cell in spleen to a few thousand in the skeletal muscle [7], liver, and
kidney.
Both subjects died of myocardial infarction and had no evidence
of cancer or occult cancer. Subject 1 was a male, age 57 years,
while subject 2 was a female, age 71 years (Table 2). This age and
gender difference may explain the difference in mtDNA copy
number in skeletal muscle between the two subjects.
Recurrence of Site-Specific Heteroplasmy
Unexpectedly, we found eight sites to be heteroplasmic in the
same tissues in both of our subjects (Figure 2). Contamination was
unlikely since the pattern of these sites fit no known haplogroup,
and the samples from the two subjects were collected at different
times and sequenced at different facilities (see Materials and
Methods). Most of these variants exist in the general population
but are rare (Table S2) [8]. Some of these variants have been
previously reported as being heteroplasmic in these same tissues
but the recurrence and tissue-specificity of these mtDNA
variations was not discussed [9]. In the four unrelated individuals
combined from our study and that of He et al [9] there were 10
recurrent mutations. All of the recurrent mutations lay within the
mtDNA control region, and nine of the ten recurrent mutations
occurred in multiple individuals but only in specific tissues (site
16093 was the only exception and this mutation was found in a
wide range of tissues). Six of the recurrent mutation sites were
observed in both studies (Figure 2). Surprisingly, these recurrent
tissue-specific mutations are all close to regulatory sites for mtDNA
replication, indicating that these variations are likely to alter the
replication dynamics of the mutated mtDNA molecules.
Three of the ten tissues studied (liver, kidney and skeletal
muscle) harbored multiple mtDNA mutations that were shared
across two or more of the four individuals combined from both
studies (Figure 2). Mutations at sites 60 and 72 occurred in liver
and kidney in both studies, while mutations at sites 94 and 203
were repeatedly detected in liver and/or kidney only in our
subjects. Of these mutations, three sites (60, 72 and 94) when
present in an individual, always occurred in both liver and kidney.
Another three occurred in skeletal muscle of all four patients (sites
64, 189 and 408). Heteroplasmy at positions 189 and 408 has been
found in skeletal muscle of the elderly [10]. A mutation at site 67
was found only in skeletal muscle in our two subjects. There was
no observable linkage disequilibrium among the sites (all pairwise
r2,0.007), indicating that these are independent mutations and
are not due to contamination. Heteroplasmy for these tissue-
specific recurrent mutations ranged from 1–21%, but was not
detected in the other tissues. Strikingly, the level of heteroplasmy
was similar across individuals in the same tissues (Figure 2). The
depth of sequence coverage in these tissues (skeletal muscle, liver
and kidney) ranged from 27,000–76,0006 (Figure 1A), providing
high confidence in our observation of heteroplasmy in these
samples. Of the tissues we examined (with the notable exception of
brain white matter), skeletal muscle, liver and kidney are the ones
most often affected by mitochondrial disease [11].
Although the entire mtDNA genome was sequenced to high
depth, we found no single base pair substitutions outside the
control region that were repeated between individuals. The
common 4977 deletion [12,13,14] was found in many tissues as
expected. Here we have focused only on those heteroplasmic sites
common to multiple subjects; the full list of identified hetero-
plasmic sites is given in Table 1. These data clearly indicate a non-
random distribution (6.0e24,p,6.0e26) of recurrent heteroplas-
mic mutations that flank important regulatory elements for
mtDNA replication (Figure 2). Several of the repeated variants
were clustered (sites 60–72) near a recently reported origin of
replication for the H strand [15,16] at sites 54–57. Three of the
other repeated mutations (189, 203 and 16093) occur very near
the boundaries of the displacement loop [15]. Finally, site 408,
which was heteroplasmic in the skeletal muscle of all four
individuals, lies within the L strand promoter that initiates the
RNA primer for mtDNA replication.
One variant, 16093, was unusual in that it was observed in all
tested tissues in one subject from each study, with tissue-specific
heteroplasmy levels that were strikingly similar across these two
individuals (Figure 3; r = 0.93, p,0.003). These subjects were of
similar age (59 and 57 years), so it is possible that the 16093
heteroplasmy increases with age at different rates in different
tissues, leading to the similar heteroplasmy levels across tissues in
these subjects. The 16093 site lies within a loop of a predicted
large secondary structure of the mtDNA and is known to be hyper-
mutable [17]. Individuals with the 16093C variant in blood tend
to have C/T heteroplasmy in buccal cells [18]. In one of our
subjects and in patient 11 from He et al. [9], the 16093C variant is
the major allele in most tissues (except muscle), and these are the
same two individuals who have widespread 16093T/C hetero-
plasmy across all tested tissues (Figure 2). The similar, tissue-
dependent heteroplasmy levels at 16093 reinforce the observation
that heteroplasmy levels at other sites are also comparable across
individuals (Figures 2 and 3).
Repeated Indel Mutations
We also found two insertion/deletion (indel) somatic mutations
that were repeated across the two sequenced subjects in a tissue-
specific pattern. Both are length variations in polynucleotide tracts.
Author Summary
DNA mutations are expected to be formed randomly, thus
any reproducible pattern of DNA somatic mutations across
multiple individuals or even across organs within each
individual is highly unexpected. Using next generation
sequencing of multiple tissues from the same individuals
we found several somatic mutations in mitochondrial DNA
that appear in a heteroplasmic state in all individuals
examined, but only in particular tissues. These mutations
were only found in known regions of replication control
for the mitochondrial DNA. These data imply the presence
of tissue-specific positive selection for these variants.
Recurrent Tissue-Specific mtDNA Mutations
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The human mtDNA reference sequence (rCRS) has a stretch of six
guanines, denoted by G6, from sites 66–71. Both of our subjects
had measurable heteroplasmy for the G5 variant, decreasing the
length of this poly-G tract by one nucleotide. This variant was
found in the same four tissues in both subjects: kidney (0.9% and
3.6% in subjects 1 and 2 respectively), large bowel (0.7% and
2.4%), small bowel (1.0% and 4.3%) and the white matter of the
brain (1.9% and 3.6%). This poly-G tract is located adjacent to
Figure 1. Coverage data. (A) The coverage of the mtDNA in each tissue in the two individuals sequenced in our study. (B) The mtDNA copy
number per cell for each tissue estimated from the coverage data.
doi:10.1371/journal.pgen.1003929.g001
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one of the recurrent heteroplasmic SNPs (Figure 2). In kidney, the
G5 variant did not occur on the same reads as the heteroplasmic
variant at site 72, demonstrating that this is not a sequencing
artifact and that the variants are on different mtDNA molecules.
Considering its location, it is reasonable to hypothesize that this
poly-G length variant also affects mtDNA replication.
The second repeated heteroplasmic indel was in an 8-nucleotide
poly-A tract at positions 12418–12425. This is the longest poly-A
tract in the rCRS. In both subjects, we found the shorter A7
variant in the kidney samples only (1.0% heteroplasmy in subject 1
and 1.6% in subject 2). We also found the longer A9 variant in
both kidney samples, but at very low levels (,1%). This indel is the
only repeated mutation that we found in the coding region of the
mitochondrial genome. It is located near the start of the MT-ND5
gene (12337–14148) and causes a frameshift mutation, severely
altering almost the entire length of the ND5 protein, an essential
component of complex I of the electron transfer chain.
Molecular Validation and Replication
To confirm that the observed heteroplasmy was not due to
sequencing artifact, we performed an alternative analysis for site
G94A because it could be assayed using RFLP analysis.
Specifically, the G allele at G94A permits digestion with the
restriction enzyme BcoDI. Sensitivity of this assay was determined
using a titration of plasmid constructs with and without the
restriction site. This assay was specific to mtDNA because the
primers did not amplify nuclear DNA (Figure S1A). We detected
as low as 2.5% of the undigested variant (Figure S1B). RFLP
analysis of all samples from the two sequenced individuals
demonstrated that the tissues shown to be heteroplasmic from
the sequencing analyses had both digested and undigested bands
and were therefore heteroplasmic (Figure 4). As a negative control,
we also analyzed this site in spleen DNA and found it to be
consistent with the sequencing results (Figure 4). This result was
statistically significant (p,0.001).
To test the generality of this heteroplasmy we examined two
additional cancer-free individuals (Subjects 3 and 4 in Table 2)
using the same RFLP assay. This analysis replicated heteroplasmy
in liver in both additional subjects and in kidney in one individual.
No significant heteroplasmy was detected in spleen in either
subject, providing additional support for the tissue-specificity of
this SNP (Figure 4). The result was also statistically significant
(p,0.001).
Discussion
Previous Literature on the Recurrent Mutation Sites
Several of our observed heteroplasmic sites have been identified
in studies of human disease. The T408A mutation, which was
present in the muscle of all four sequenced individuals (two from
the present study and two from He et al.), has been reported as an
age-related somatic mutation in muscle [10,19,20,21]. It has also
been associated with disease in an investigation of a patient with a
mitochondrial depletion syndrome [22] that was fatal at a young
age (14 years), where the T408A mutation exhibited heteroplasmy
at high levels (.70%) in all investigated maternal relatives, but was
not detectible in the patient. The authors speculated that the
T408A mutation interacted with a hypothesized nuclear DNA
factor that affected mtDNA replication, thus leading to the
mtDNA depletion in this patient. The A189G mutation, which
was also present in the muscle of all four sequenced individuals,
has also been reported in studies of aging muscle
[10,19,20,21,23,24,25], and is often reported together with
T408A. Both of these mutations increase in heteroplasmy level
in muscle slowly with increasing age [19].
Heteroplasmy at site 16093 has often been reported in a range
of tissues [18,26,27,28,29,30,31,32], consistent with the observa-
tion of this variant being in all tissues in one of our two sequenced
subjects and one of the subjects from He et al. The T414G
mutation has been reported to accumulate with age in fibroblasts
and skeletal muscle [33,34] and we detected this mutation in one
individual in a skin sample (Table 1). Our observation of
heteroplasmy at 189, 408, 414, and 16093 and the previous
studies reporting these same variants provide support for the
validity of the next-generation sequencing data.
We found that four heteroplasmic somatic mutations (T60C,
T72C, G94A, and G203A) recur, but only in liver and/or
kidney. Given that liver and kidney arise from endoderm and
mesoderm respectively, it is unlikely these mutations share a
common developmental origin. These four sites are also global
population polymorphisms, though at low frequencies [8] (Table
S2). Some of these have been previously reported in the context
of human disease. The T72C variant has been reported as a
somatic mutation in the brain tissue of both Alzheimer’s cases
and controls [35], although it was not detected in any sequenced
brain samples in this study. G94A has recently been reported in
two Chinese pedigrees transmitting Lebers Hereditary Optic
Table 2. Demographics for our subjects.
Subject 1 Subject 2 Subject 3 Subject 4
Gender Male Female Male Female
Age (years) 57 71 43 73
Race White White White White
Height (cm) 173 NA 178 NA
Weight (kg) 97.2 62.6 113 246
BMI 32.5 NA 35.6 NA
Tobacco usage Yes Negative Negative Negative
Drug usage Negative Negative Negative Negative
Alcohol consumption Yes Negative Very little Negative
Cause of Death MI MI Accidental Death Sepsis (pneumonia)
MI: myocardial infarction.
NA: Not available.
doi:10.1371/journal.pgen.1003929.t002
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Neuropathy but in these families this variant was an inherited
fixed polymorphism, not a heteroplasmic somatic mutation [36].
Despite the rarity of G203A in the global population (estimated
as 0.3% in a survey of human mtDNA sequences deposited in
GenBank) [8] it has been identified as a fixed variant in patients
with deafness in two independent studies in different ethnicities
[37,38].
Implications of the Recurrent Mutations
Our results indicate that mtDNA heteroplasmy due to somatic
mutation is unexpectedly recurrent and tissue specific. By using a
sensitive deep-sequencing technique across a wide range of tissues
in multiple subjects we were able to test the hypothesis that specific
mtDNA variations preferentially accumulate in particular tissues
[34,39]. One possible explanation for observing the same mtDNA
heteroplasmic variants in two or more tissue types within the same
person is that a mutation occurred early in embryonic develop-
ment, before the tissues differentiated from their common
progenitor. However, this hypothesis cannot explain the repeated
observation of the same mutations in the same tissues in unrelated
individuals. The occurrence of repeated mutations in the same
tissues at sites that closely correspond to regulatory elements for
mtDNA replication indicates somatic selection as the most likely
mechanism driving the increase and maintenance of these
heteroplasmic mutations. This inference is further supported by
independent evidence that liver and kidney exhibit positive
selection for mtDNA variants in a mouse model formed by
artificially mixing the mtDNA of two different mouse strains
[40,41,42]. In-vivo BrdU labeling in these mice over a time course
of 50 hours did not detect any difference in labeling in liver
samples between the two mtDNA haplotypes [41], leading the
authors to conclude that replicative advantage was not the driving
force for the segregation in these mice. However, we would argue
that a 50 hour window is not comparable to the decades of
replication advantage that would need to occur in our subjects.
Recently, Sharpley et al [43] also generated a separate mouse
model of heteroplasmy by mixing the naturally occurring NZB
and 129S6 mtDNA sequences. This mouse model also showed
that the segregation of the two mtDNA genomes varied in a tissue-
specific manner, with liver and kidney having the strongest
Figure 2. Graphical representation of the human mtDNA control region (sites 576-1 and 16569-16024). All sites found to be
heteroplasmic in two or more subjects are listed, with measured percent heteroplasmy given after each tissue name. SM – skeletal muscle. H – heavy
strand of mtDNA, L – light strand, OH1 and OH2 – origins of replication of the heavy strand. Site numbering is from rCRS.
doi:10.1371/journal.pgen.1003929.g002
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selection for the NZB version of the genome. Finally, liver has
been argued to be under selection for nuclear aneuploidy and
polyploidy, indicating that selection may have a special role in this
tissue [44]. It is reasonable that the tissue specific selection of these
mtDNA variants is due to regulation by nuclear-encoded
mitochondrial genes with tissue-dependent expression, as has
been shown in one of the mouse models in spleen [40]. In contrast
to previous work documenting a wide variety of heteroplasmic sites
and their functional implications, the unique value of this study is
the comparison of mtDNA heteroplasmy across multiple tissues in
several individuals and the demonstration that several somatic
variants recur in a tissue-specific pattern.
The pattern of tissue-specific mutations we have found across
multiple individuals could be explained by a few alternatives,
including positive or negative selection. Under positive selection,
mutations in certain tissues would increase in frequency due to
their advantage. Under negative selection, mutations could occur
at a high rate but would be removed from all tissues except for
those where the recurrence is observed, where negative selection is
presumably relaxed. Of these two alternatives, positive selection is
the most likely explanation because under negative selection
mutations should be scattered widely across the mtDNA control
region, not just the recurrent ones at specific sites related to
replication (Figure 2). In contrast, positive selection could simply
be explained by a replication or other functional advantage in high
copy number tissues due to increased mtDNA replication. It is
important to note than any functional difference among the
variant mtDNA molecules, if any, are due only to the sites we
describe because all of our observed heteroplasmic sites are
independent of each other, and there were no recurrent
heteroplasmic sites in the coding regions.
Another alternative is that there are tissue-specific mutational
hotspots within the mtDNA. For example, interferon-induced
cytidine deaminases are capable of generating somatic mtDNA
mutation in a tissue-specific fashion [45]. Although this alternative
is not mutually exclusive to the selection argument, we still favor
differential selection based on its simplicity, and on prior data
suggesting that two of the tissues in which we observed recurrent
mtDNA mutations, liver and kidney, also undergo selection in two
separate heteroplasmic mouse models [40,41,42,43]. The mouse
models provide evidence suggesting that selection in the absence of
any de-novo mutation generation can cause tissue specific hetero-
plasmy patterns because in both mouse models the two mtDNA
haplotypes were artificially introduced through cell fusion and
were not generated via a mutation process. Furthermore, even if
the heteroplasmic sites we observed are mutational hotspots, their
locations in the mtDNA genome are highly suggestive of
functional roles (Figure 2). Homoplasmy in tumors has also been
shown to possibly derive from random processes alone, but this
computer simulation study is not directly analogous to recurrent
Figure 3. Tissue dependent heteroplasmy levels of the 16093 T/C variant across two subjects. The heteroplasmy levels in these two
subjects have a correlation of 0.93 (p = 0.003). The diagonal line shows equal values in the two subjects. Patient 11 is from He et al. [9].
doi:10.1371/journal.pgen.1003929.g003
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heteroplasmy in normal tissues of multiple individuals [46].
Therefore, the most parsimonious and reasonable explanation
for our data is positive selection in liver, kidney and skeletal muscle
for certain mutations in and around the regions controlling
mtDNA replication.
In a very different model system (i.e. a mouse strain with an
abnormally high mutation rates due to a defective mtDNA
polymerase) evidence for lower mutation load in the D loop was
described [47]. Specifically, in this mouse model the accumulation
of point mutations in the mtDNA was lower in the D loop region
than the rest of the mtDNA. It is impossible to determine
conclusively from these data whether this pattern is due to
selection or to a variation in mutation rate, but it does demonstrate
a non-random pattern in this part of the mtDNA, something we
also observed but in a different direction.
Our data provide strong support for the conclusion that the
current models of mtDNA variation are inadequate to explain
what we now call ‘‘recurrent heteroplasmy’’. The pattern of
common, recurrent mutations we observed provides strong
evidence that mtDNA heteroplasmy at several sites is non-random
and is most likely the result of tissue-specific positive selection
acting on the replication of mtDNA. The restriction of these
mutations to liver, kidney and skeletal muscle indicates that the
mtDNA replication process may vary across tissues, leading to
tissue-specific selective forces, which correspond with high copy
number tissues.
Materials and Methods
Tissue Collection
The protocols were approved by the Vanderbilt University
Institutional Review Board. Samples were collected at autopsy
within 48 hours post-mortem by a trained pathologist (RDH).
Tissue samples for DNA extraction were collected using clean and
sterile scalpels, placed in petri dishes, and transferred to 50 ml
tubes containing ice-cold Dulbecco’s phosphate-buffered saline
(DPBS), rinsed again with DPBS and stored at 280uC until DNA
extraction with exceptions as described below. Separate portions
of the tissue sections were preserved in 10% formalin. Skin
samples were collected from the ventral torso, from both above-
belt (Skin-AB) and below-belt (Skin-BB) (e.g. above or below the
waistline). Skeletal muscle was obtained from the diaphragm. The
small and large bowel samples consisted of mucosal tissue that was
collected by carefully scraping the loose mucosal layer from the
internal surface of bowel sections. Bone marrow tissue was
collected by flushing rib or vertebral body sections with DPBS and
collecting the flushed material in a 50 ml tube on ice, which was
then centrifuged to collect the cellular material. Splenocytes were
isolated as previously described [48]. Gray and white brain
samples were separated manually in a petri dish using a sterile
scalpel. Demographic information for the four subjects is in
Table 2.
DNA Extraction
For each tissue two DNA extractions were performed. The
tissue was lysed using the DNeasy Blood and Tissue Kit (Qiagen
69504). Once the tissue was lysed and incubated at 56uC
overnight, one set of DNA extractions was transferred into a
2.0 ml tube (Sarstedt 72.694.406) and put on the QIAsymphony
for automated extraction (Qiagen). The protocols used on the
QIAsymphony were Tissue_LC_200_V5 and Tis-
sue_HC_200_V5 depending on the tissue type. The second set
of DNA extractions was transferred to Autopure Qubes D
(Qiagen 949022) and 3 ml of Cell Lysis Solution (Qiagen 949006)
was added to each tissue sample. These samples were then placed
on the Autopure LS (Qiagen) for automated extraction. The
protocol used on the Autopure was Cell Lysate. The resulting
DNA was stored in Nunc Cryotubes (Nunc 377267). DNA from
each protocol was calibrated and samples combined prior to
sequencing.
Figure 4. Mutation at position 94 is verified by RFLP analysis. DNA isolated from kidney (K), liver (L), and spleen (S) from subjects 1, 2, 3 and 4
were subjected to PCR and RFLP analysis. The presence of the mutation at position 94 is seen as the presence of the upper (uncut) band by gel
electrophoresis. RFLP analysis of PCR products from wild type (94G), mutant (94A), and mixed (2.5% 94A) plasmid DNA are also loaded for
comparison.
doi:10.1371/journal.pgen.1003929.g004
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Sequencing and Data Processing
Sequences were generated as 100 nt paired-end reads on
Illumina HiSeq 2000 machines. The two subjects were
sequenced at different locations (subject 1 at Macrogen in
South Korea and subject 2 at Illumina in California). Each
sample was sequenced on 3–5 lanes, yielding 1.14–1.99 billion
reads, which were aligned to the human reference genome
hg19+rCRS (revised Cambridge Reference Sequence,
NC_012920.1) using BWA [5] (ver. 0.5.9-r16). We performed
local realignment and base quality score recalibration using
GATK [6] (ver. 1.0.5974). The number of mapped reads ranged
from 1.09–1.84 billion, with more than 90% of all reads being
mapped except skeletal muscle from subject 2 (86.2%) (Table
S1). Other programs were also used at various steps: samtools
(ver. 0.1.16) for sorting and indexing bam files, bamtools (ver.
0.8.1025) for splitting and merging bam files, and picard
(version 1.48) for marking duplicates and fixing mates after local
realignment.
All samples were also genotyped on the Illumina Human
Omni1 Quad chip with approximately one million SNPs in the
nuclear genome. The consistency rate between the sequence- and
chip-based SNP calls was .99.86% for all samples after standard
quality control filtering. This indicates that the sequencing data
were of high quality.
Identification of Heteroplasmy and Testing for Artifacts
Due to Non-Circularity of the Reference Genome
We screened for heteroplasmy in mtDNA using reads with
MAPQ$30. For each site, we calculated the fraction of bases A,
C, G, T on the forward and reverse strands. A site was called
heteroplasmic if it had $1% frequency for two or more bases on
both strands and the variant did not have any of the following
alignment artifacts: 1) strand bias, 2) clustering at read ends, and 3)
low average base quality score. Due to the high read depth
(Figure 1, Table S1) all duplicate reads were retained. Hetero-
plasmy estimates were assessed with and without the duplicate
reads and heteroplasmy levels were not influenced by the
duplicates.
The linear mtDNA reference genome (rCRS) was created by
cutting the circular mtDNA at a fixed position. This may generate
alignment artifacts near the linearization site (i.e., the ends of the
mtDNA reference): 1) a read overlapping the linearization site may
be unmapped or require heavy clipping to be aligned, 2) a read
may be aligned but its paired-end mate may not be, and 3) a read
may be aligned to one end of the reference but its mate to the
other end. As a result, reads close to the linearization site may have
low mapping quality scores and may be disproportionately filtered
out. As our data are 100 nt reads with insert sizes mostly between
250 bp and 400 bp (Figure S2), these artifacts may influence the
results hundreds of bases away from the mtDNA ‘‘ends’’. To
prevent artifacts due to mtDNA circularity we also created a new
mtDNA reference genome by shifting the rCRS starting point to
position 7002, and repeated the whole data processing steps as
described above. Heteroplasmy was virtually identical between the
two alignments, with less than 0.1% difference in heteroplasmy
estimates.
In addition, the artificial N base at 3107 of the rCRS reference
can lead to alignment artifacts. This N was removed before the
alignment was made.
Tests for Other Potential Sequencing Artifacts
For all observed heteroplasmic sites, we checked for various
sequencing artifacts. The mtDNA control region harbors multiple
poly-nucleotide tracts that could lead to sequencing artifacts. Since
these artifacts often have strand bias, we filtered out all sites with
strand bias. In addition, for each heteroplasmic site we performed
a motif analysis similar to that described in detail for site 310 in the
supplementary material, to identify artifacts (Table S4). We also
checked for the presence of artifacts due to sequence similarities
between the nuclear and mtDNA genomes (NUMT), and none
could be detected (see Text S1). The reported sites are free of any
artifacts.
Distributions of Cycle and Strand for the Mutant Alleles
Alignment errors are known to cause artifacts that often show
strand bias and excessive occurrence of mutant alleles at read ends.
We found no cycle (i.e. position on the read) or strand bias for the
mutant alleles at the heteroplasmic sites we identified. We
extracted all bases with mapping quality score $30 and base
quality score $20 at each heteroplasmic site and compared the
distributions of cycle and strand for the major and mutant alleles.
Figure S3 shows the distributions of C and A alleles for site 64 in
the skeletal muscle of Subject 1. The mutant allele was uniformly
distributed across the read length on both strands, showing no
strand or cycle bias. Other heteroplasmic sites we identified had
similar patterns.
Levels of Linkage Disequilibrium between Heteroplasmic
Sites
For heteroplasmic sites close enough to be on the sameDNA read
or read pair, we assessed whether the minor alleles are on the same
haplotype background, or in other words, if they are in linkage
disequilibrium (LD). LD between the variants could be a sign of
either contamination or sequencing artifacts. Specifically, for every
pair of sites#100 bp apart (e.g., 60-72-94 in liver and kidney tissues
and 64–67 in skeletal muscles), we extracted reads that covered both
positions and had MAPQ$30. We further required that the reads
had all bases matched (i.e., CIGAR string ‘‘100M’’) or had clipping
at one end (i.e., CIGAR string matching the regular expression
pattern ‘‘[0–9]*S[0–9]*M’’ or ‘‘[0–9]*M[0–9]*S’’), and the bases at
the two sites had base quality score$20. We then tallied haplotypes
and calculated r2 between the two sites. All r2 values were very close
to zero (,0.004), indicating no LD between any heteroplasmic sites.
For every pair of sites .100 bp apart (e.g. between 60-72-94
and 203 in liver tissues; among 64–67, 189, and 408 in skeletal
muscles), we extracted read pairs that covered both positions and
had MAPQ$30 and then followed the above procedure. Again,
all r2 values were very close to zero (,0.007), indicating no LD in
the mtDNA.
Sequencing Error Rate
The sequencing error rate is reflected in the recalibrated base
quality scores. For example, a base quality (BQ) score of 25 means
the error rate for that base is 0.32%, BQ=27 means 0.2%, and
BQ=30 means 0.1%. These error rates are much lower than the
1% detection cutoff we used for the determination of hetero-
plasmic sites. Figure S4 shows the distribution of recalibrated base
quality scores. For all our samples, 82.4% bases had recalibrated
base quality score $30, 91.4% had scores $27, and 94.4% had
scores$25. These results provide assurance that the bases we used
for our inferences had high quality and an error rate much lower
than our heteroplasmy detection threshold.
Estimation of mtDNA Copy Number
We calculated the depth of coverage for autosomes and mtDNA
as:
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100|number of reads with MAPQ§20ð Þ
number of nonN bases in the referenceð Þ
The multiplier 100 was used because we had 100 nt reads. The
mtDNA depth ranged from 56516–1192036, and the autosome
depth ranged 376–616 (Table S1). Assuming each cell carries a
diploid (26) nuclear genome, the mtDNA copy number was
estimated as:
mtDNA depth
autosome depth=2ð Þ
The estimated mtDNA copy number ranged from 315 to 5880
(Table S1).
Statistical Tests
To test for non-randomness of the recurrent mutations, we
calculated the probability that a mutation occurred at these 10
sites under two extreme scenarios. Using a model of constant
mutation rate, c, along the whole mtDNA genome, the probability
for a mutation to occur anywhere would be 16569c and the
probability for it to occur at these 10 sites would be 10c. Thus the
probability for an observed mutation in a DNA sample to occur
only at any of these 10 sites is 10/16569= 6.0e24. Now suppose a
mutation has been observed in a specific tissue of an individual.
The probability to observe the same mutation in another
individual only in the same tissue (out of 10 tissues) and on the
same site (out of 10 sites) is further reduced to 6.0e26. The
recurrence patterns of the reported mutations fall between these
two extreme scenarios, and therefore their p-values are between
6.0e24 and 6.0e26.
To test for correlation of 16093 heteroplasmy levels between the
two individuals (Figure 3), we calculated the Pearson correlation
coefficient and its associated p-value. The correlation was 0.93 and
the p-value was 0.0028.
We calculated the p-value to evaluate the significance of our
RFLP validation and replication results. For the validation part,
we performed RFLP on six tissues (kidney, liver, spleen from
Subjects 1–2). Let a=P(detect 94A|94A is absent), the probability
of falsely detecting 94A in RFLP analysis while it was absent. Then
the probability of seeing 94A in two kidneys, two livers but not the
two spleens is a4(12a)2. The value of a is probably lower than the
false positive rate for sequencing analysis, which would be at most
0.2 (4 out of 20 tissues when the sequencing results were assumed
to be false). Even at a=0.2, the p-value will be a4(12a)2 = 0.001.
The p-value will be much smaller at a lower value of a; for
example, p=5.6e26 if a=0.05, and p=9.8e29 if a=0.01. The p-
value for the replication part can be similarly evaluated.
Haplogroup Determination
We determined the mtDNA haplogroups for our subjects: T2a1
for subject 1 and H1a1 for subject 2 (Table S3). Haplogrouping
was performed using the H-Mito program (http://www.phylotree.
org) supplied by Mannis van Oven [49].
RFLP Analysis
To provide molecular validation of sequencing results, we
performed RFLP analysis using control plasmids and patient DNA
from suspected heteroplasmic and homoplasmic tissues. We
focused on position 94, which sequencing results identified as
heteroplasmic in kidney and liver. Control samples consisted of
100% wild-type plasmids at position 94 (G), 100% mutant
plasmids (A), or 97.5% wild-type and 2.5% mutant plasmids.
DNA samples from suspected heteroplasmic kidney and liver
tissues, and from suspected homoplasmic spleen tissue were
analyzed for subjects 1–4. Fifteen nanograms of the control
plasmid or patient DNA was amplified with 10 mM D-loop-
targeted forward (59-GATCACAGGTCTATCACCCTATTA-
AC-39) and reverse (59-CAGATACTGCGACATAGGGTGCT-
39) primers (Operon) and Platinum PCR Supermix (Invitrogen)
according to manufacturer’s directions. Following amplification,
PCR products were digested for 8 h at 37uC with the restriction
enzyme BcoDI, which cuts the wild-type but not mutant PCR
product at position 94. Successful digestion resulted in cutting of
the 130-bp PCR product into 90- and 40-bp fragments. We added
5 mL 56gel-loading dye (KD Medical/MediaTech) to each 20-uL
reaction after restriction digest, and loaded 12 mL of digest
products and gel-loading dye into each well of a 3% agarose
(Sigma) gel in 16TBE (Cellgro) with 0.0125% ethidium bromide
(Bio-Rad). The gel was run at 150 V for 2 h, then UV imaged for
200 ms in a Syngene G:Box imager.
Supporting Information
Figure S1 RFLP analysis can detect low levels of mutation at
position 94. (A) PCR using primers surrounding position 94 of the D
loop of the mtDNA amplify a 130 bp fragment from HeLa cell or
human brain total DNA. No amplification is seen when rho zero
(lacking mtDNA) cell DNA is used as template, indicating no
amplification from nuclear mtDNA insertions (nuMTs). (B)
Sensitivity of RFLP analysis. Mixtures of plasmids containing a
wild type (94G) or mutant (94A) allele were used to determine the
sensitivity of the RFLP analysis. Plasmid mixtures were subjected to
PCR and the amplified DNA fragments were digested with BcoDI.
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Figure S2 Distribution of mtDNA insert size for subject 1 (left) and
subject (right). To address these issues, we created a new mtDNA
reference genome, starting at position 7002 and without the N base at
3107. We then aligned all reads, using hg19 and this new mtDNA
reference to compare with the alignment to the original rCRS. The
list of heteroplasmic sites was the same for both alignments.
Heteroplasmy levels were estimated using the alignment for which
the linearization site was more distant from the evaluated site. All
heteroplasmic sites had only two alleles with$1% frequency and one
of the two alleles was always the reference allele in the rCRS.
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Figure S3 Distributions of cycle for bases C and A at site 64 in
the skeletal muscle of Subject 1.
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Figure S4 Distribution of base quality score after recalibration
for subject 1 (left) and subject 2 (right).
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Table S1 Summary of sequencing
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Table S2 Sequence properties of the recurrent heteroplasmic
sites
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Table S3 Haplogroup information for our subjects: Alleles at
non-heteroplasmic sites that differ from the rCRS reference are
shown. The alleles are fixed in all tissues except for 16126, which
was heteroplasmic in two tissues of Subject 1 (Table 1). Site 16093
is also included because its major allele is not the reference allele in
all but one tissue of Subject 1.
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